Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$686M |
| 2 |
Merck
MRK
|
+$536M |
| 3 |
GoDaddy
GDDY
|
+$330M |
| 4 |
CSX Corp
CSX
|
+$227M |
| 5 |
Aramark
ARMK
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$372M |
| 2 |
DexCom
DXCM
|
+$339M |
| 3 |
Broadcom
AVGO
|
+$321M |
| 4 |
Adobe
ADBE
|
+$280M |
| 5 |
Meta Platforms (Facebook)
META
|
+$273M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.38% |
| 2 | Healthcare | 16.14% |
| 3 | Financials | 13.58% |
| 4 | Industrials | 12.86% |
| 5 | Consumer Discretionary | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTRL
1376
DELISTED
Control4 Corporation
CTRL
| $294K | ﹤0.01% |
+8,563
| New | +$264K |
|
|
NXTM
1377
DELISTED
NxStage Medical Inc.
NXTM
| $293K | ﹤0.01% |
10,505
+2,134
| +25% | +$60K |
|
1378
Madrigal Pharmaceuticals
MDGL
$12.6B
| $288K | ﹤0.01% |
1,343
+454
| +51% | +$114K |
|
|
EFOR
1379
Everforth Inc
EFOR
$845M
| $284K | ﹤0.01% |
3,595
+999
| +38% | +$86.3K |
|
1380
Cavco Industries
CVCO
$4.39B
| $283K | ﹤0.01% |
+1,118
| New | +$259K |
|
1381
The Ensign Group
ENSG
$10.1B
| $283K | ﹤0.01% |
7,980
+83
| +1% | +$2.89K |
|
1382
CareTrust REIT
CTRE
$10.2B
| $282K | ﹤0.01% |
15,908
+2,944
| +23% | +$51.9K |
|
1383
MiMedx Group
MDXG
$626M
| $281K | ﹤0.01% |
45,404
+28,428
| +167% | +$128K |
|
1384
Brookdale Senior Living
BKD
$3.62B
| $278K | ﹤0.01% |
28,234
+700
| +3% | +$6.44K |
|
|
FOCS
1385
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $278K | ﹤0.01% |
+5,863
| New | +$250K |
|
1386
TD Synnex
SNX
$19.4B
| $277K | ﹤0.01% |
6,544
+1,498
| +30% | +$72.2K |
|
1387
Builders FirstSource
BLDR
$7.84B
| $276K | ﹤0.01% |
+18,784
| New | +$318K |
|
1388
Barclays
BCS
$94.1B
| $269K | ﹤0.01% |
31,467
| – | – |
|
1389
iRhythm Holdings
IRTC
$3.59B
| $267K | ﹤0.01% |
+2,822
| New | +$246K |
|
1390
Vipshop
VIPS
$6.84B
| $266K | ﹤0.01% |
42,600
-3,930,993
| -99% | -$32.3M |
|
|
LTC
1391
LTC Properties
LTC
$2.16B
| $264K | ﹤0.01% |
5,980
-10,829
| -64% | -$474K |
|
1392
Ameris Bancorp
ABCB
$5.89B
| $263K | ﹤0.01% |
+5,744
| New | +$285K |
|
|
JBTM
1393
JBT Marel
JBTM
$7.14B
| $259K | ﹤0.01% |
+2,170
| New | +$236K |
|
1394
LCI Industries
LCII
$2.51B
| $258K | ﹤0.01% |
+3,110
| New | +$291K |
|
1395
Usana Health Sciences
USNA
$394M
| $258K | ﹤0.01% |
+2,140
| New | +$266K |
|
1396
PC Connection
CNXN
$2.05B
| $255K | ﹤0.01% |
+6,557
| New | +$243K |
|
1397
WPP
WPP
$4.04B
| $255K | ﹤0.01% |
3,477
| – | – |
|
1398
iShares MSCI Hong Kong ETF
EWH
$1.22B
| $252K | ﹤0.01% |
10,527
+430
| +4% | +$10.4K |
|
|
SFBS
1399
ServisFirst Bancshares
SFBS
$4.79B
| $252K | ﹤0.01% |
+6,426
| New | +$272K |
|
|
BLD
1400
DELISTED
TopBuild
BLD
| $250K | ﹤0.01% |
+4,396
| New | +$313K |
|
Similar funds
Janus Henderson Group's Q3 2018 Portfolio in Review
As of Q3 2018, Janus Henderson Group held 1,505 positions worth $187B, up 6.7% from $175B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Janus Henderson Group's Q3 2018 filing shows 118 new, 660 increased, 620 reduced and 63 closed positions. Its largest new stake was Elanco Animal Health: 1,976,916 shares worth $69M. The largest sale was Biogen, an estimated $372M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2018 buy was Elanco Animal Health: 1,976,916 shares worth $69M.
- Janus Henderson Group added most to Apple in Q3 2018, an estimated $686M increase.
- Janus Henderson Group's biggest Q3 2018 reduction was Biogen, cutting an estimated $372M.
- Janus Henderson Group fully exited Financial Engines, Inc. in Q3 2018, selling an estimated $190M.
- Janus Henderson Group's ten largest holdings make up 16% of its $187B portfolio in Q3 2018.
- Janus Henderson Group opened 118 new positions and closed 63 in Q3 2018.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $187B.
Based on Janus Henderson Group's 13F filing for Q3 2018, filed 9 Nov 2018.